Consolidated Statements of Income (USD $) In Millions, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Net Sales	$ 58,167	[1]	$ 57,080	[1]	$ 56,786	[1]
Cost of sales	47,464		47,594		47,792
Research and development expenses	1,647		1,747		1,708
Selling, general and administrative expenses	3,106		3,024		2,861
Amortization of intangibles	436	[2]	461	[2]	478	[2]
Goodwill and other intangible asset impairment losses	50	[3]	0		220	[3]
Restructuring charges (credits)	(3)	[4]	(22)	[4]	1,343	[4]
Asbestos-related charge	78	[5]	0		0
Equity in earnings of nonconsolidated affiliates	835		1,034		536
Sundry income (expense) - net	(27)		2,554		(27)
Interest income	51		41		41
Interest expense and amortization of debt discount	983		1,101		1,269
Income Before Income Taxes	5,265		6,804		1,665
Provision for income taxes	1,426		1,988		565
Net Income	3,839		4,816		1,100
Net income (loss) attributable to noncontrolling interests	67		29		(82)
Net Income Attributable to The Dow Chemical Company	3,772		4,787		1,182
Preferred stock dividends	340	[6]	340		340	[6]
Net Income Available for The Dow Chemical Company Common Stockholders	$ 3,432		$ 4,447		$ 842
Per Common Share Data:
Earnings per common share - basic (in dollars per share)	$ 2.91		$ 3.72		$ 0.71
Earnings per common share - diluted (in dollars per share)	$ 2.87		$ 3.68		$ 0.70
Common stock dividends declared per share of common stock	$ 1.53		$ 1.28		$ 1.21
Weighted-average common shares outstanding - basic	1,170.9		1,186.2		1,169.7
Weighted-average common shares outstanding - diluted	1,187.0		1,290.4		1,176.4

[1] The Indian subcontinent, previously reported with Rest of World, is now aligned with Europe, Middle East, Africa and India; prior period sales and long-lived assets have been adjusted to reflect this realignment.

[2] Includes a $3 million asset impairment charge related to intangible assets in 2013.

[3] See Note 11 for information regarding intangible asset impairment losses and Note 9 for information regarding the goodwill impairment loss.

[4] See Note 3 for information regarding restructuring charges and credits.

[5] See Note 14 for information regarding the asbestos-related charge.

[6] Preferred stock dividends were not added back in the calculation of diluted earnings per share for the periods ended December 31, 2014 and December 31, 2012 because the effect of adding them back would have been antidilutive.